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ABSTRACT:

Mass spectrometry is a method that uses masses to determine the structure of a
compound. This is completed by first charging the compound until it is a cation or anion, and
then its molecular weight can be determined by measuring a mass to charge ratio. The focus of
this study was determination of sphingomyelin’s structure. The purpose of this was that
sphingomyelin has been shown to play a critical role in many biological pathways and being able
to identify this lipid could prove to be beneficial for preventative medicine. Utilizing
electrospray ionization (ESI) Quadruple-Time-of-flight (Q-TOF) mass spectrometry on a Waters
Synapt instrument and matrix-assisted laser desorption ionization (MALDI) TOF-TOF mass
spectrometry on a Bruker UltraFlex III instrument, it was possible to verify the presence of a
sphingolipid as well as the tail length and the presence of double bonds.
INTRODUCTION:
The human body is composed of various macromolecules, which include proteins, lipids,
and carbohydrates. Lipids have a wide range of physiological importance and they play a crucial
role in compartmentalization of cells and organelles. For example, the lipid bilayer is a regulator
of cellular transport and acts as a membrane that allows necessary concentration gradients to
form. Lipids are categorized by their constituents, which include fatty acid tails, a backbone
structure, and head groups.
The primary focus of my project is the characterization of a sphingomyelin lipid.
Sphingomyelin is the most common of the sphingolipids in mammals.1 The typical components
of sphingomyelin are phosphocholine, sphingosine, and a fatty acid as depicted in figure 1.
Sphingomyelin has been shown to be involved in cellular signaling as well as membrane
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Figure 1 shows the shingomyelin lipid being analyzed. As one can see the phosphocholine is
depicted in red and the sphingosine shown in blue. While the variable fatty acid tail is shown in black.

composition.2 Typically this is done through the formation of lipid rafts composed of cholesterol,
sphingomyelin, and glycosphingolipids.1 Due to lipid rafts favorable environment for many
signaling proteins such as G proteins, Src family kinases, and growth factor receptors, they are
effectively able to promote or inhibit signal relays.1
Sphingomyelin has been shown to be involved in various other body pathways as well.
Increased sphingomyelin levels are responsible for uptake of cholesterol, as the lipids often form
complexes together on cell membranes.3 Conversely, low cholesterol levels cause the body to
release it from cells more rapidly. In fact, sphingomyelin plays a role in recruitment of
cholesterol transporters to the plasma membrane.1 However, excessive amounts of
sphingomyelin can also be harmful. One such example is how sphingomyelin can impact insulin
resistance. Studies have indicated decreasing sphingomyelin results in fewer lipid rafts, which
increased insulin sensitivity.1 One study found that by decreasing glycosphingolipids, insulin
sensitivity was increased in both the liver and muscle of mice.4 Therefore high levels of
sphingomyelin could contribute to type 2 diabetes. Another concern is sphingomyelin’s presence
in cancer cells. More specifically it was shown that prostate and breast cancer cells had higher
levels of sphingomyelin in their membranes.5 However, another study showed that regular intake
of sphingomyelin proved to decrease tumor growth for colon cancer induced in mice.6 Further
studies are needed to understand the function of sphingomyelin in regulating cellular apoptosis.
Since, sphingomyelin has been shown to play an important role in many biological processes, the

ability to detect its presence and chain length are crucial to serve as a preventative health
screening and potentially disease treatment.
Although mass spectrometry cannot give insight into how sphingomyelin functions in
biological pathways, it does offer a method of detection at very low concentrations. It also can
serve as a screening technique if further studies show certain lengths or saturations of the fatty
acid tails are the source of bodily harm.
In order to detect sphingomyelin at low concentrations and with such detail, high
precision instrumentation must be used. The instrumentation for this analysis will include an
electrospray ionization (ESI) Q-TOF mass spectrometer and a matrix-assisted laser desorption
ionization (MALDI) TOF-TOF mass spectrometer. Both of these instruments provide extremely
accurate readouts with mass precision to 0.001daltons in the instruments. Both instruments
require the sample to be in the gas state and under vacuum; however, their methods of ionizing
are quite different. ESI initially has the compound of interest dissolved in a volatile liquid such
as chloroform. The solution is then sprayed through a charged capillary in order to ionize the
sample. Conversely, MALDI has the sample dried on a plate with a matrix suitable for the
sample. A laser then hits the sample and causes it to be desorbed and ionized. MALDI is
typically reserved for use on larger molecules including proteins, carbohydrates, and lipids.7
Readout for both instrumentation systems is presented in the form of peaks detected based on
their mass to charge ratio and abundance.

MATERIALS and METHODS:
Sphingomyelin (23:0) extracted from
bovine milk was purchased in powder form
(Avanti Polar Lipids, Alabaster, AL). The lipid had
a variety of fatty acid chain lengths which require
the use of an analytical method capable of
determining these lengths. The chain distribution
data that was provided by Avanti Polar Lipids can
be seen in figure 2.

Figure 2: The following figure shows the
sphingomyelin distribution as described by
the Avanti Polar Lipids. Lipid in the highest
concentration is (23:0). As one can see the
sample was not completely pure and some
unknown lipid structures were present.

ESI- Synapt:
Analysis was performed using a Waters Synapt G1 Q_TOF tandem mass spectrometer coupled
with ESI. Methanol, chloroform, NaI, and LiI were purchased from Sigma Aldrich (Sigma
Aldrich, St. Louis, MO). Samples were prepared by creating a 0.1mg/mL solution of
sphingomyelin in chloroform. Samples were made in small quantities to preserve the
sphingomyelin in its stable solid form. It was important to use glass vials for the preparation as
plastic showed rapid lipid degradation. Lipids were then vortexed to ensure they were fully
dissolved and distributed in the chloroform. In another vial, 0.1 mg/mL of NaI or LiI was created
in methanol. This solution was also vortexed to ensure that the salts were fully dissolved.
Samples were loaded into a 250 µL syringe. 125 µL of each the lipid and salt solution were
loaded. Therefore the final concentration of the lipid being tested was 0.05 mg/mL dissolved in
equal amounts of chloroform and methanol with a small amount of salt added to promote better
ionization. Additional information between the differences of using NaI or LiI can be found in

the discussion. The samples were run at a flow rate of 5 µL per minute. Tandem mass
spectrometry (MS/MS) experiments were performed by collisional activated dissociation (CAD)
using argon as a collision gas. Samples were run primarily in positive mode because the lipid
studied more readily formed cations. Data analysis was later performed using Walters’
MassLynx software.
MALDI:
Analysis was performed using a Bruker UltraFlex III MALDI-TOF-TOF (tandem timeof-flight) mass spectrometer. Again chloroform, NaI, and DCTB matrix were purchased from
Sigma Aldrich (Sigma Aldrich, St. Louis, MO). A 10 mg/mL solution of sphingomyelin was
made using chloroform in a glass vial. DCTB was dissolved in methanol (20 mg/mL) and NaI in
methonal (10 mg/mL). Then DCTB, the sample, and NaI salt were mixed together in the ratio of
10:5:1 respectively. This mixture was then spotted on the plate and allowed to dry. PMMA,
Poly(methyl methacrylate), was used for calibration and prepared using the above procedure.
Samples were then run with adjustments made to the laser power to maximize signal intensities.
Data analysis was performed using Bruker’s DataAnalysis software.
RESULTS/DISCUSSION:
The initial results (figure 3 in appendix) showed many peaks clustered between 600-900
Da. Examining these peaks more closely revealed a common mass difference of 14.02 Da
between adjacent peaks. This is the mass of -CH2- group and makes sense, as the sample was
known to contain sphingomyelin with varying fatty acid chain lengths. The results showed a
great diversity of samples found in the lipid samples ranging form sphingomyelin (24:0) to
(13:0). This was surprising to see such a great variety in fatty acid lengths, but it was known that

the sample was not synthetic and therefore variations were expected. Also a cluster of peaks
occurred in the 900-1000 Da range. These peaks were determined to be the lipids found in the
700- 900 Da range with the addition of a NaI. The calculated mass of sodiated sphingomyelin
(23:0), the main product of the lipid sample according to supplier (shown in figure 4 is 837.6820
Da, which is very close to the mass found experimentally, 837.6807 Da. A large peak at
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Figure 4 shows how sphingomyelin appears when sodiated and shows the expected mass
of the lipid. Initial experimental results show a very similar mass with a mass accuracy of 1.55 ppm.

398.2484 Da was also present, but upon further analysis this was present in many different lipid
samples and likely is a byproduct of the purification process. After that tandem mass
spectrometry (MS/MS) experiments were performed on the identified peaks in order to gain
insight into each sphingomyelin’s breakdown pathways and structure.
The 837.6701 m/z peak was then isolated and fragmented using MS/MS giving a few
major peaks at 778.5999 m/z, 654.8009 m/z, and 184.0860 m/z as can be seen in figure 5 located
in the appendix. Upon analysis it was determined that fragmentation would occur between
different regions of the sphingomyelin head. As one can see in figure 6 one fragment is formed
by loss of a partial region of the head; while figure 7 shows that the other fragment is formed by
loss of the entire head group.
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Figure 6 shows the loss of only a portion of the sphingomyelin head group.
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Figure 7 shows the loss of the entire sphingomyelin head group.

Likewise all the other major peaks showed similar results after MS/MS was performed,
which can be seen in figures 5, 8-10 in appendix 3. At this point it was clear that regardless of
the fatty acid tail length, fragmentation would occur at the head group. The experiment was
performed again to verify that the trends were reproducible as seen in figure 11 in the appendix.
Also, additional peaks were isolated and fragmented to see if they would react in a similar
fashion. These results can be seen in figures 12-18 in appendix 3. Results were almost identical
to the first set obtained showing that if conditions are consistent the lipids can be identified using
these methods. Also, table 1 shows the ppm error of the major lipid peaks for all the different
runs. One interesting note was that all of the MALDI data showed significantly higher error
relative to the ESI data. However upon further examination one will notice that all of the
experimental MALDI peaks were lower than the expected mass by roughly 0.35 Da. Therefore
the MALDI did have high precision, but had low accuracy that could be corrected in future runs
by a recalibration.

The next step was to use LiI salt to potentially help see additional peaks as the Li would
more strongly bind to the lipid and cause it to form more fragment ions. Indeed, when LiI was
added, one saw peaks with higher intensities and a few more peaks were present. This is because
the lithium was able to more readily remain bound and form cations with different fragments of
the sphingomyelin and these charged fragments were now detected by the Synapt. These results
can be seen in figure 19-23 in appendix 3. Due to sphingomyelin not having a great deal of
complexity beside its fatty acid tail, the extra fragments from using lithium as a salt were not
beneficial. They did show the head group peak better (184.0733 m/z).
Finally the sphingomyelin was run on MALDI in order to see if similar results could be
obtained using a different ionization method. The results were promising as peaks were detected
with the characteristic 14 Da spacing as well as matching in masses. One limitation of MALDI
was that it typically is used to determine masses of larger samples. Therefore results below a few
hundred Da are not reliable due to interference between the matrix and sample. Therefore some
of the smaller products from fragmentation were not visible such as the phosphocholine (184
Da). As one can see in figure 24 the MALDI was able to identify the different sized
sphingomyelin. All together MALDI proved to be an alternative method to study the
sphingomyelin.
CONCLUSION:
Overall, the experimentation proved to be insightful into how sphingomyelin’s structure
is broken down under stress in a gas phase. It was shown that multiple methods of mass
spectrometry could be used to characterize sphingomyelin including ESI and MALDI. Also the
benefits of using ESI were shown as a great amount of detail was obtains from subsequent

fragmentation. Finally, it was shown that sphingomyelin prefers to fragment between its
backbone and phosphocholine head group, and that this trait could likely be used to distinguish
sphingomyelin from other lipids or molecules.
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Appendix 1: Safety Considerations
Due to the nature of any lab dealing with chemicals a few safety measures must be taken
regardless of the chemical used. This includes the use of gloves and safety eyewear at all times.
Many of the chemicals being dealt with in the laboratory are flammable and volatile and
therefore it is important to keep a clean work environment and work dealing with chemicals
should be done under the hood. At the conclusion of dealing with chemicals it is important to
dispose of them properly. For the chemicals used in this lab they are to all be placed under the
specified waste hood and allowed to fully evaporate. At that time the vials or test tubes can be
disposed or cleaned. If a spill is to occur the area should be cleared and the lab should be
ventilated if the spill is significant.
Another concern in the lab is the handling of glass vials and syringes. If any glassware breaks
one is to immediately clean the glassware up using a broom. Cleaning broken glassware should
never be done without safety eyewear or gloves. Glass waste containers are located throughout
the lab and all glass waste should be disposed there.
Finally, the mass spectrometer instrumentation is very precise and made to detect very small
concentrations of samples. Therefore cleaning is often required before and after running samples
to completely clean the instrumentation. Therefore it is very important that instruments are put
on hold when being cleaned. Also, it is important to always wear eye protection and gloves as
cleaning involves different solvents to help break down the sample residues.
Below are recommendations if an individual comes in contact with some of the most used
chemicals in lab.
1) Exposure to sphingomyelin

a) If sphingomyelin is inhaled or ingested one should immediately contact a physician and
the individual should be taken to an area with fresh air. If the individual feels sick
emergency responders should be notified immediately to better direct the individual.
b) If sphingomyelin comes in contact with one’s eyes or skin they should thoroughly clean
the affected area using an eye wash station or sink for at least 15 minutes. If irritation is
present a physician should be contacted.
2) Methanol
a) If methanol is inhaled or ingested one should immediately contact a physician and the
individual should be taken to an area with fresh air. If the individual feels sick emergency
responders should be notified immediately to better direct the individual.
b) If methanol comes in contact with one’s eyes or skin they should thoroughly clean the
affected area using an eye wash station or sink for at least 15 minutes. If irritation is
present a physician should be contacted.
3) Chloroform
a) If chloroform is inhaled or ingested one should immediately contact a physician and the
individual should be taken to an area with fresh air. If the individual feels sick emergency
responders should be notified immediately to better direct the individual.
b) If chloroform comes in contact with one’s eyes or skin they should thoroughly clean the
affected area using an eye wash station or sink for at least 15 minutes. If irritation is
present a physician should be contacted.

4) Sodium Iodide (NaI) or LiI

a) If sodium iodide is inhaled or ingested one should immediately contact a physician and
the individual should be taken to an area with fresh air. If the individual feels sick
emergency responders should be notified immediately to better direct the individual.
b) If sodium iodide comes in contact with one’s eyes or skin they should thoroughly clean
the affected area using an eye wash station or sink for at least 15 minutes. If irritation is
present a physician should be contacted.

Appendix 2: Calculations

Calculating how much chloroform needs to be added in order to make a sample 0.1mg/mL was
performed using the equation:
(Volume of chloroform to add) = (mass of lipid in vial in milligrams)/ (0.1 milligrams)

Example:
0.01 grams of sphingomyelin were weighed out. That is equal to 1 milligram. Therefore
in order to get to a concentration of 0.1mg/mL 10 mL of chloroform must be added.

Determining the differences in mass between peaks for data was done by subtracting the peaks
respective mass/charge ratios. Since only sphingomyelin was tested double and triple charged
peaks were not present.
Example:
Peak 1 (m/z) – Peak 2 (m/z) = Difference in Da
Reference figure 11
809.5700 

750.4994 

Calculation of PPM Error:

59.0706 

Observed mass: mass obtained from instrumentation
Exact mass: Theoretical mass calculated from summing the elements with consideration their
respective isotopes.
      
 10
   
Example:
Reference Figure 5 peak A
Observed mass: 736.5580 Da
Exact mass: 736.5621 Da
736.5580 Da 736.5621 Da
 10
736.5621 Da

5.5664 ""

#$%& $ & ' 5.5664 ppm

Appendix 3: Mass Spectrometry Data

See attachment

